Sartorius AG is a global enterprise specializing in comprehensive bioprocess solutions and laboratory products and services. Its extensive portfolio includes advanced analytical instruments such as biosensors, label-free detection systems, SPR technology, live-cell analysis platforms, and flow cytometry apparatus, complemented by a range of cell analysis reagents and consumables. The company manufactures diverse cell culture media tailored for applications spanning antibody and recombinant protein production, viral vaccine development, regenerative medicine, and stem cell research. It also supplies a variety of general media, downstream buffers, microcarriers, strong acids, bases, alcohols, and detergents. Sartorius is a leading provider of bioreactor technologies, offering multi-parallel, benchtop, single-use, stainless steel, cell culture, and microbial models, often integrated with dedicated software applications. A significant portion of its offerings includes a broad array of filtration products: membranes, blotting materials, filter papers, glass and quartz microfibre products, and various filtration devices for ultrafiltration, sterile filtration, harvesting, analytical and diagnostic sample preparation, buffer exchange, particle analysis, pharmaceutical processes, protein/DNA concentration, venting moisture barriers, and clarification. This segment also features syringe filters, buffer and media products, and membrane chromatography solutions. Further expanding its catalog, Sartorius supplies process filtration and chromatography products, fluid management solutions, process analytical technology with data analytics, industrial microbiology systems, water purification units, precision weighing and pipetting/dispensing systems, OEM components, and centrifuges. Beyond products, the company delivers crucial services such as bioprocess development and engineering, protein expression system support, media and process optimization, testing, instrument services, and validation. Serving a wide array of sectors, Sartorius supports life science research, biopharmaceutical manufacturing, quality control and testing, and various applied industries. Established in 1870, this long-standing enterprise maintains its headquarters in Göttingen, Germany.
The current price of SRT0.MU is €57.50 EUR — it has increased by +0.88% in the past 24 hours. Watch Sartorius stock price performance more closely on the chart.
What is Sartorius stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Sartorius stocks are traded under the ticker SRT0.MU.
Is Sartorius stock price growing?▼
SRT0.MU stock has risen by +0% compared to the previous week, the month change is a +11.65% rise, over the last year Sartorius has showed a +23.92% increase.
When is the next Sartorius earnings date?▼
Sartorius is going to release the next earnings report on February 23, 2027.
What were Sartorius earnings last quarter?▼
SRT0.MU earnings for the last quarter are 1.28 EUR per share, whereas the estimation was 1.26 EUR resulting in a +1.54% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Sartorius revenue for the last year?▼
Sartorius revenue for the last year amounts to 3.54B EUR.
What is Sartorius net income for the last year?▼
SRT0.MU net income for the last year is 129.14M EUR.
Does Sartorius pay dividends?▼
Yes, SRT0.MU dividends are paid annual. The last dividend per share was 0.14 . As of today, Dividend Yield (FWD)% is 0.25%.
How many employees does Sartorius have?▼
As of November 7, 2026, the company has 14,042 employees.
In which sector is Sartorius located?▼
Sartorius operates in the Health & Wellness sector.